Everest Medicine Placement - Third Deal in the Year, Previous Ones Didn’t Do Well
Everest Medicines (1952 HK) aims to raise around US$200m via a top-up placement. In this note, we run the deal through our framework and talk about...
502 Views
A/H Premiums & Recent Listings Performance-Changing Trends but Quality Matters More than the Premium
With a spate of A/H listings already done in the first half and a lot more in the pipeline, we look at some of the trends from the recent listings.
662 Views
A-H Premium Weekly (Jul 18th): Livzon Pharmaceutical, Cosco Shipping Development, Beigene
We analyzed A-H premium changes in the past week and highlight A-H premium changes for Livzon Pharmaceutical, Cosco Shipping Development, Beigene,...
359 Views
Unisplendour Corp A/H Listing - Growth Slowing, Margins Dropping
Unisplendour Corporation Limited (000938 CH), an ICT infrastructure products provider, aims to raise around US$1bn in its H-share listing. In this...
445 Views
Muyuan Foods A/H Listing - Long Term Growth with Short-Term Volatility
Muyuan Foodstuff Co Ltd A (002714 CH), a leader in the hog farming industry, aims to raise around US$2bn in its H-share listing. In this note, we...
698 Views